The shareholders in Modus Therapeutics Holding AB (publ), reg. no. 556851-9523 (the “Company”), are hereby invited to attend the extraordinary general meeting to be held in the offices of Setterwalls Advokatbyrå, Sturegatan 10 in Stockholm, on 23 March 2018 at 10:00 a.m.
Conditions for participation
Shareholders who wish to attend the meeting shall be entered in the Company’s share register at the date of the meeting. Shareholders who wish to attend shall also give notice of attendance to the Company’s counsel Linnea Gävbo at Setterwalls Advokatbyrå either via letter to Setterwalls Advokatbyrå AB, Attn: Linnea Gävbo, P.O. Box 1050, SE-101 39 Stockholm, Sweden or by e-mail to email@example.com no later than 19 March 2018. Notification shall include full name, personal- or corporate identity number, address, daytime telephone number, and, if applicable, information about proxy or representative. Shareholders attending by proxy or representative should send documents of authorisation to Linnea Gävbo (address above) in good time before the meeting.
A shareholder represented by proxy shall issue a power of attorney which shall be dated and signed by the shareholder. If issued by a legal entity the power of attorney shall be accompanied by registration certificate or, if not applicable, equivalent documents of authority. Power of attorney forms for those shareholders wishing to participate by proxy are available on the company’s website www.modustx.com. The original version of the power of attorney shall also be presented at the meeting.
- Opening of the meeting and election of chairman of the meeting.
- Preparation and approval of the voting register.
- Election of one or two persons to certify the minutes.
- Approval of the agenda.
- Determination as to whether the meeting has been duly convened.
- Determination of number of board members and deputy board members
- Election of new board member.
- Closing of the meeting.
Resolutions proposed by the board
Item 6: The board of directors proposes that the extraordinary general meeting resolves that the board of directors shall consist of six ordinary board members with one deputy board member for the period until the close of the next annual general meeting.
Item 7: The board of directors proposes that the extraordinary general meeting resolves to elect Miroslav Reljanovic as a new ordinary board member for the period until the close of the next annual general meeting.
Information at the extraordinary general meeting
The board of directors and the CEO shall, if requested by a shareholder, and if the board of directors’ believes that it can be done without material harm to the Company, provide information regarding circumstances that may affect the assessment of a matter on the agenda or of the Company’s financial situation.
The board of directors’ proposed resolution is disclosed in its entirety in this notice.
Stockholm in March 2018
The board of directors